MINNEAPOLIS, Sept. 15 /PRNewswire-FirstCall/ -- CNS, Inc. , the Breathe Right(R) company, today announced that it has entered into a three-year, exclusive distribution agreement with Grisi Hnos., S.A. de C.V., to sell Breathe Right Tan and Clear nasal strips in Mexico. CNS will begin shipping products to Grisi later this fiscal year. The over-the-counter consumer healthcare market in Mexico is the ninth largest in the world, with approximately $1 billion in annual retail sales.
"Mexico represents an exciting, new market with significant growth potential," said Marti Morfitt, president and chief executive officer of CNS, Inc. "We are pleased to partner with Grisi as we further expand CNS' international distribution."
CNS currently sells its products in 27 countries, spanning Europe, Japan, Canada, Australia and the United States.
Grisi, based in Mexico City, was founded in 1863 and is an established leader in manufacturing, marketing and distributing consumer products within the health, beauty, hygiene and nutrition product categories.
About CNS, Inc.
CNS, based in Minneapolis, designs and markets consumer health care products, including Breathe Right(R) nasal strips, Breathe Right Snore Relief(TM) throat spray, and the newly introduced Breathe Right Vapor Shot!(TM) personal vaporizer, as well as FiberChoice(R) chewable fiber tablets. The company focuses on products that address important consumer needs within the aging well/self-care market, including better breathing and digestive health. Its common stock is listed on the Nasdaq National Market under the ticker symbol "CNXS." More information about CNS and its products is available at http://www.cns.com/ .
Some of the information contained in this news release is forward-looking and subject to certain business risks as described in the company's filings with the Securities and Exchange Commission, including those referred to in its Annual Report on Form 10-K for the year ended March 31, 2004. This news release contains forward-looking statements, which involve risks and uncertainties.
CNS, Inc.CONTACT: Sam Reinkensmeyer, Chief Financial Officer of CNS, Inc.,+1-952-229-1500, sreinkensmeyer@cns.com ; or Shawn Brumbaugh,sbrumbaugh@psbpr.com , or Marian Briggs, mbriggs@psbpr.com , both of PadillaSpeer Beardsley Inc., +1-612-455-1700
Web site: http://www.cns.com/
